JAMA Dermatology

<jats:sec id="ab-doi240012-4"><jats:title>Importance</jats:title><jats:p><jats:italic>Trichophyton indotineae</jats:italic> is an emerging dermatophyte causing outbreaks of extensive tinea infections often unresponsive to terbinafine. This species has been detected worldwide and in multiple US states, yet detailed US data on infections with <jats:italic>T indotineae</jats:italic> are sparse and could improve treatment practices and medical understanding of transmission.</jats:p></jats:sec><jats:sec id="ab-doi240012-5"><jats:title>Objective</jats:title><jats:p>To correlate clinical features of <jats:italic>T indotineae</jats:italic> infections with in vitro antifungal susceptibility testing results, squalene epoxidase gene sequence variations, and isolate relatedness using whole-genome sequencing.</jats:p></jats:sec><jats:sec id="ab-doi240012-6"><jats:title>Design, Setting, and Participants</jats:title><jats:p>This retrospective cohort study of patients with <jats:italic>T indotineae</jats:italic> infections in New York City spanned May 2022 to May 2023. Patients with confirmed <jats:italic>T indotineae</jats:italic> infections were recruited from 6 New York City medical centers.</jats:p></jats:sec><jats:sec id="ab-doi240012-7"><jats:title>Main Outcome and Measure</jats:title><jats:p>Improvement or resolution at the last follow-up assessment.</jats:p></jats:sec><jats:sec id="ab-doi240012-8"><jats:title>Results</jats:title><jats:p>Among 11 patients with <jats:italic>T indotineae</jats:italic> (6 male and 5 female patients; median [range] age, 39 [10-65] years), 2 were pregnant; 1 had lymphoma; and the remainder were immunocompetent. Nine patients reported previous travel to Bangladesh. All had widespread lesions with variable scale and inflammation, topical antifungal monotherapy failure, and diagnostic delays (range, 3-42 months). Terbinafine treatment failed in 7 patients at standard doses (250 mg daily) for prolonged duration; these patients also had isolates with amino acid substitutions at positions 393 (L393S) or 397 (F397L) in squalene epoxidase that correlated with elevated terbinafine minimum inhibitory concentrations of 0.5 μg/mL or higher. Patients who were treated with fluconazole and griseofulvin improved in 2 of 4 and 2 of 5 instances, respectively, without correlation between outcomes and antifungal minimum inhibitory concentrations. Furthermore, 5 of 7 patients treated with itraconazole cleared or had improvement at the last follow-up, and 2 of 7 were lost to follow-up or stopped treatment. Based on whole-genome sequencing analysis, US isolates formed a cluster distinct from Indian isolates.</jats:p></jats:sec><jats:sec id="ab-doi240012-9"><jats:title>Conclusion and Relevance</jats:title><jats:p>The results of this case series suggest that disease severity, diagnostic delays, and lack of response to typically used doses and durations of antifungals for tinea were common in this primarily immunocompetent patient cohort with <jats:italic>T indotineae</jats:italic>, consistent with published data. Itraconazole was generally effective, and the acquisition of infection was likely in Bangladesh.</jats:p></jats:sec>

Epidemiological trends in skin mycoses worldwide.

Mycoses

New antifungal agents and new formulations against dermatophytes.

Mycopathologia

A US epidemiologic survey of superficial fungal diseases.

J Am Acad Dermatol

Terbinafine-resistant dermatophytes and the presence of trichophyton indotineae in North America.

J Clin Microbiol

The emergence of Trichophyton indotineae: implications for clinical practice.

Int J Dermatol

Trichophyton indotineae sp. nov.: a new highly terbinafine-resistant anthropophilic dermatophyte species.

Trichophyton indotineae—an emerging pathogen causing recalcitrant dermatophytoses in India and worldwide—a multidimensional perspective.

J Fungi (Basel)

MIC and upper limit of wild-type distribution for 13 antifungal agents against a Trichophyton mentagrophytes—Trichophyton interdigitale complex of Indian origin.

Antimicrob Agents Chemother

Spread of terbinafine-Resistant Trichophyton mentagrophytes type VIII (India) in Germany—“the tip of the iceberg?”.

The unprecedented epidemic-like scenario of dermatophytosis in India: I. epidemiology, risk factors and clinical features.

Indian J Dermatol Venereol Leprol

The unprecedented epidemic-like scenario of dermatophytosis in India: III. antifungal resistance and treatment options.

Effect of different itraconazole dosing regimens on cure rates, treatment duration, safety, and relapse rates in adult patients with tinea corporis/cruris: a randomized clinical trial.

JAMA Dermatol

Limited effectiveness of four oral antifungal drugs (fluconazole, griseofulvin, itraconazole and terbinafine) in the current epidemic of altered dermatophytosis in India: results of a randomized pragmatic trial.

Br J Dermatol

Point mutations in the squalene epoxidase gene of Indian ITS genotype VIII T. mentagrophytes identified after DNA isolation from infected scales.

Med Mycol Case Rep

Alarming India—wide phenomenon of antifungal resistance in dermatophytes: a multicentre study.

Extensive dermatophytosis caused by terbinafine-resistant Trichophyton indotineae, France.

Emerg Infect Dis

Correlation of in vitro susceptibility based on MICs and squalene epoxidase mutations with clinical response to terbinafine in patients with tinea corporis/cruris.

Oral isotretinoin combined with oral terbinafine versus oral terbinafine alone to treat recurrent dermatophytosis: an open-label randomised clinical trial.

Indian Dermatol Online J

Efficacy and safety of 250 mg versus 500 mg oral terbinafine in the treatment of tinea corporis and cruris: a randomised, assessor-blinded comparative study.

Notes from the field: first reported US Cases of tinea caused by Trichophyton indotineae—New York City, December 2021-March 2023.

MMWR Morb Mortal Wkly Rep

Gene amplification of CYP51B: a new mechanism of resistance to azole compounds in Trichophyton indotineae.

Highly accurate protein structure prediction with AlphaFold.

Nature

SWISS-MODEL: an automated protein homology-modeling server.

Nucleic Acids Res

Fast, accurate, and reliable molecular docking with QuickVina 2.

Bioinformatics

AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.

J Comput Chem

UCSF ChimeraX: structure visualization for researchers, educators, and developers.

Protein Sci

The emergence and worldwide spread of the species Trichophyton indotineae causing difficult-to-treat dermatophytosis: a new challenge in the management of dermatophytosis.

PLoS Pathog

Phylogeny, antifungal susceptibility, and point mutations of SQLE gene in major pathogenic dermatophytes isolated from clinical dermatophytosis.

Front Cell Infect Microbiol

Emergence of terbinafine resistant Trichophyton mentagrophytes in Iran, harboring mutations in the squalene epoxidase (SQLE) gene.

Infect Drug Resist

Mutation in the squalene epoxidase gene of Trichophyton interdigitale and Trichophyton rubrum associated with allylamine resistance.

Structure and inhibition mechanism of the catalytic domain of human squalene epoxidase.

Nat Commun

Trichophyton indotineae is an emerging dermatophyte causing outbreaks of extensive tinea infections often unresponsive to terbinafine. This species has been detected worldwide and in multiple US states, yet detailed US data on infections with T indotineae are sparse and could improve treatment practices and medical understanding of transmission.
To correlate clinical features of T indotineae infections with in vitro antifungal susceptibility testing results, squalene epoxidase gene sequence variations, and isolate relatedness using whole-genome sequencing.
This retrospective cohort study of patients with T indotineae infections in New York City spanned May 2022 to May 2023. Patients with confirmed T indotineae infections were recruited from 6 New York City medical centers.
Improvement or resolution at the last follow-up assessment.
Among 11 patients with T indotineae (6 male and 5 female patients; median [range] age, 39 [10-65] years), 2 were pregnant; 1 had lymphoma; and the remainder were immunocompetent. Nine patients reported previous travel to Bangladesh. All had widespread lesions with variable scale and inflammation, topical antifungal monotherapy failure, and diagnostic delays (range, 3-42 months). Terbinafine treatment failed in 7 patients at standard doses (250 mg daily) for prolonged duration; these patients also had isolates with amino acid substitutions at positions 393 (L393S) or 397 (F397L) in squalene epoxidase that correlated with elevated terbinafine minimum inhibitory concentrations of 0.5 μg/mL or higher. Patients who were treated with fluconazole and griseofulvin improved in 2 of 4 and 2 of 5 instances, respectively, without correlation between outcomes and antifungal minimum inhibitory concentrations. Furthermore, 5 of 7 patients treated with itraconazole cleared or had improvement at the last follow-up, and 2 of 7 were lost to follow-up or stopped treatment. Based on whole-genome sequencing analysis, US isolates formed a cluster distinct from Indian isolates.
The results of this case series suggest that disease severity, diagnostic delays, and lack of response to typically used doses and durations of antifungals for tinea were common in this primarily immunocompetent patient cohort with T indotineae, consistent with published data. Itraconazole was generally effective, and the acquisition of infection was likely in Bangladesh.

Clinical Course, Antifungal Susceptibility, and Genomic Sequencing of Trichophyton indotineae.

Clinical Course, Antifungal Susceptibility, and Genomic Sequencing of <i>Trichophyton indotineae</i>

Clinical Course, Antifungal Susceptibility, and Genomic Sequencing of <i>Trichophyton indotineae</i>

Clinical Summary

What was studied

Key findings

Study limitations

Clinical implications

Related Questions